Trade Desk's 39% post-earnings selloff is a market overreaction, creating a highly attractive risk/reward entry for a ...

For the quarter, Voya Multi-Manager International Small Cap Fund outperformed the S&P Developed ex-U.S. Small Cap Index and ...

HighPeak's Q2'25 oil production dropped 11%, extends debt maturities to 2028, and boosts liquidity by $180M. Click here for HPK stock's full investment analysis.

SoundHound AI reports record Q2 revenues, but weak 2025 guidance raises growth concerns. Read here for an investment analysis ...

Credit Suisse High Yield Bond has an impressive 8.75% yield, 2.75% NAV discount, and strong diversification. Read here for ...

Titan Machinery struggles with revenue declines and rising expenses amid tough market conditions. Read here for more analysis ...

Ladder Capital beats Q2 EPS estimates, improves payout metrics, and diversifies its portfolio, making LADR a top choice for ...

Golub Capital's strong 2.4% NAV return, 10.55% dividend yield, and diversified portfolio. See why GBDC is a steady, ...

Schwab Fundamental Emerging Markets Equity ETF has global diversification with growth potential, attractive valuations, and a ...

In July, equities remained the most actively traded ETF asset class, comprising 65% of the overall platform flow. In a ...

Explore Inovio Pharmaceuticals' Q2 2025 earnings call highlights, including progress on INO-3107, regulatory milestones, financial updates, and ...

Good afternoon, ladies and gentlemen, and welcome to the Inovio Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Tuesday, August 12, 2025.